COVID-19 and Comorbidities: What Has Been Unveiled by Metabolomics?

showed a decreasing trend of FT3 level with increasing severity of COVID-19, suggesting that patients with low levels of this hormone may experience severe adverse COVID-19 effects [ 142 ].

also in 47,180 other papers

These observations have been highly significant throughout the course of the pandemic, since they assisted physicians in making decisions based on the presence or absence of pre-existing conditions or on patients’ daily habits, such as smoking or medication usage.

also in 132,142 other papers